Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA - NASDAQ:BWAY - US10501L1061 - ADR

14.78 USD
-0.4 (-2.64%)
Last: 11/18/2025, 8:00:02 PM
14.78 USD
0 (0%)
After Hours: 11/18/2025, 8:00:02 PM
Fundamental Rating

6

Taking everything into account, BWAY scores 6 out of 10 in our fundamental rating. BWAY was compared to 188 industry peers in the Health Care Equipment & Supplies industry. BWAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BWAY is growing strongly while it also seems undervalued. This is an interesting combination This makes BWAY very considerable for value and growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BWAY was profitable.
In the past year BWAY had a positive cash flow from operations.
In the past 5 years BWAY reported 4 times negative net income.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of BWAY (4.79%) is better than 80.85% of its industry peers.
BWAY has a Return On Equity of 7.84%. This is amongst the best in the industry. BWAY outperforms 80.85% of its industry peers.
BWAY has a Return On Invested Capital of 1.83%. This is in the better half of the industry: BWAY outperforms 69.15% of its industry peers.
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROIC 1.83%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BWAY's Profit Margin of 11.60% is amongst the best of the industry. BWAY outperforms 85.64% of its industry peers.
BWAY has a better Operating Margin (4.05%) than 68.09% of its industry peers.
With an excellent Gross Margin value of 74.52%, BWAY belongs to the best of the industry, outperforming 85.11% of the companies in the same industry.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
Industry RankSector Rank
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWAY is destroying value.
The number of shares outstanding for BWAY has been increased compared to 1 year ago.
The number of shares outstanding for BWAY has been increased compared to 5 years ago.
BWAY has a worse debt/assets ratio than last year.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 4.03 indicates that BWAY is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.03, BWAY is doing good in the industry, outperforming 75.53% of the companies in the same industry.
BWAY has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
The Debt to FCF ratio of BWAY (0.33) is better than 92.55% of its industry peers.
BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
BWAY's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. BWAY outperforms 64.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Altman-Z 4.03
ROIC/WACC0.21
WACC8.73%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.51 indicates that BWAY has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.51, BWAY is doing good in the industry, outperforming 64.36% of the companies in the same industry.
A Quick Ratio of 3.34 indicates that BWAY has no problem at all paying its short term obligations.
BWAY's Quick ratio of 3.34 is fine compared to the rest of the industry. BWAY outperforms 71.28% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 3.34
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 260.14% over the past year.
BWAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.04%.
Measured over the past years, BWAY shows a quite strong growth in Revenue. The Revenue has been growing by 12.17% on average per year.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.27% yearly.
The Revenue is expected to grow by 19.29% on average over the next years. This is quite good.
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.96, which indicates a correct valuation of BWAY.
BWAY's Price/Earnings ratio is rather cheap when compared to the industry. BWAY is cheaper than 87.77% of the companies in the same industry.
When comparing the Price/Earnings ratio of BWAY to the average of the S&P500 Index (25.51), we can say BWAY is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 9.80, the valuation of BWAY can be described as reasonable.
93.09% of the companies in the same industry are more expensive than BWAY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.98. BWAY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.96
Fwd PE 9.8
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BWAY indicates a somewhat cheap valuation: BWAY is cheaper than 65.43% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 90.96% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15
EV/EBITDA 54.36
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

BWAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 53.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y54.54%
EPS Next 3Y53.27%

0

5. Dividend

5.1 Amount

No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield N/A

BRAINSWAY LTD-ADR

NASDAQ:BWAY (11/18/2025, 8:00:02 PM)

After market: 14.78 0 (0%)

14.78

-0.4 (-2.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/dmh
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners5.13%
Inst Owner Change-5.46%
Ins Owners16.62%
Ins Owner ChangeN/A
Market Cap280.87M
Revenue(TTM)41.02M
Net Income(TTM)5.34M
Analysts85.71
Price Target0.12 (-99.19%)
Short Float %0.46%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)36.24%
Min EPS beat(2)-22.64%
Max EPS beat(2)95.12%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.15%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)-18.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)32.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-12.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 12.96
Fwd PE 9.8
P/S 6.09
P/FCF 15
P/OCF 12.13
P/B 4.12
P/tB 4.12
EV/EBITDA 54.36
EPS(TTM)1.14
EY7.71%
EPS(NY)1.51
Fwd EY10.2%
FCF(TTM)0.99
FCFY6.67%
OCF(TTM)1.22
OCFY8.25%
SpS2.43
BVpS3.59
TBVpS3.59
PEG (NY)0.22
PEG (5Y)N/A
Graham Number9.59
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROCE 2.17%
ROIC 1.83%
ROICexc 19.56%
ROICexgc 19.56%
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
FCFM 40.64%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Debt/EBITDA 1.37
Cap/Depr 229.33%
Cap/Sales 9.62%
Interest Coverage 11.81
Cash Conversion 609.66%
Profit Quality 350.45%
Current Ratio 3.51
Quick Ratio 3.34
Altman-Z 4.03
F-Score4
WACC8.73%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y155.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.13%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y321.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y429.93%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


What is the valuation status for BWAY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


What is the valuation of BRAINSWAY LTD-ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRAINSWAY LTD-ADR (BWAY) is 12.96 and the Price/Book (PB) ratio is 4.12.